This study is the first to elucidate the synergistic mechanism by which BSHXF drug-containing serum combined with ADSCs delays IDD through regulation of the miR-199a-3p/TGF-β/Smad signaling pathway. The gene discussed is TGFB1; the disease is intervertebral disk degenerative disorder.